Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
NAMSW
#11072
NewAmsterdam Pharma Company N.V. Ordinary Shares
23.400
0
USD
-0.43%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-0.43%
Monthly Change
+30.00%
6 month change
-14.63%
Year Change
+254.55%
Previous Close
23.500
0
Open
23.500
0
Bid
Ask
Low
23.400
0
High
23.730
0
Volume
12
Markets
US Stock Market
Healthcare
NAMSW
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
109.82 M
112.27 M
112.63 M
113.39 M
114.98 M
—
Valuation ratios
Enterprise value
—
—
—
—
—
—
Price to earnings ratio
-5.57
-4.89
-5.06
-8.51
-13.43
-31.89
Price to sales ratio
29.51
18.26
12.7
52.58
121.57
205.11
Price to cash flow ratio
-8.48
-6.36
-6.89
-13.12
-18.51
-44.88
Price to book ratio
1.78
0.39
0.32
0.62
4
5.34
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
-0.11
-0.05
-0.02
-0.09
-0.1
-0.26
Return on equity %
-0.12
-0.05
-0.02
-0.1
-0.11
-0.28
Return on invested capital %
-594.54
—
—
-259.21
-174.23
—
Gross margin %
63.69
-96.14
77.6
-816.95
-31.09 K
-31.92 K
Operating margin %
-338.47
-2 314.47
-186.13
-15.85 K
-206.19 K
-224.53 K
EBITDA margin %
-374.38
-2 508.87
-208.3
-16.74 K
-237.19 K
-256.65 K
Net margin %
-721.71
-1 327.3
-90.7
-20.69 K
-234.13 K
-256.24 K
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
8.08
19.98
21.08
12.57
7.88
61.51
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.02
0
0.02
0
0
0.03
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-0.4
-0.31
-0.32
-0.28
-0.35
-1.25
EBIT per share
-0.51
-0.64
-0.34
-0.49
-0.64
-2.11
EBITDA per share
-0.51
-0.64
-0.34
-0.49
-0.64
-2.11
Total debt per share
—
—
—
—
—
—
Cash per share
8.84
6.96
6.23
5.91
5.37
24.48
Net current asset value per share
9.15
7.04
6.49
6.15
5.71
25.39
Tangible book value per share
8.02
6.69
6.56
6.11
5.77
25.13
Working capital per share
8.02
6.69
6.19
5.66
4.98
23.52
Book value per share
8.03
6.69
6.57
6.12
5.77
25.15
News
AMG TimesSquare Small Cap Growth Fund Q4 2025 Performance Insights
NewAmsterdam: Obicetrapib MAA Filings Merit Continued 'Buy' Rating (NASDAQ:NAMS)
abrdn Life Sciences Investors Q1 2025 Commentary
abrdn World Healthcare Fund Q4 2024 Commentary (NYSE:THW)